🇺🇸 FDA
Patent

US 7585622

Increasing the proliferative capacity of cells using telomerase reverse transcriptase

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7585622 (Increasing the proliferative capacity of cells using telomerase reverse transcriptase) held by The Regents of the University of Colorado expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00, A61P